Private equity interest in the healthcare and life sciences sectors has continued to grow at a rapid pace during recent years. Many investors are becoming increasingly more knowledgeable and comfortable with investments involving direct patient care and reimbursement risk, while … Continue Reading
PACE operators may become the next target of interest for healthcare private equity investors following a first-of-its-kind acquisition of a PACE operator by private equity sponsor Welsh Carson Anderson & Stowe (WCAS), which plans to acquire Denver-based InnovAge for $206m.… Continue Reading
DocuTAP has announced that it has been acquired by Warburg Pincus.
DocuTAP, based in Sioux Falls, S.D., is a provider of urgent care technology, including software for electronic medical records, practice management and revenue cycle management.
We have co-written a column with Scott Becker and Bart Walker, McGuireWoods partners, and Brooke Murphy, Becker’s Healthcare writer, on “Private Equity In Healthcare – A Review of 15 Niche Investment Areas” for Becker’s Hospital Review.
The article provides … Continue Reading
Council Capital has announced it has closed its third PE fund, Council Capital III, LP.
Advent International has announced it will acquire a majority ownership interest in ATI Physical Therapy (ATI) from KRG Capital Partners.
Sverica Capital Management has announced it has closed its fourth private equity fund — Sverica Capital Partners Fund IV LP — at its hard cap of $275 million.
An increase in attention to and awareness of gender equality in private equity is a step in the right direction, experts say in a Law360 column.
Synlogic has announced it has secured $40 million in series B financing.
Synlogic, based in Cambridge, Mass., is a biopharmaceutical company focused on the development of a class of therapeutics, called synthetic biotics. Synlogic’s two lead therapeutic programs are … Continue Reading
Our partner Scott Downing and I published a piece in AAOS Now last month that I thought investors might also be interested in.
In the past decade, the list of investors that have put their capital to work in the healthcare and life sciences industries has grown dramatically. Healthcare and life sciences offer some undeniable opportunities that continue to fuel investor interest, and … Continue Reading
“We’re looking for a symbiotic platform that will have a disruptive effect in a rapidly expanding ecosystem.” A private equity colleague of ours described this conversation, which he overheard at the most recent J.P. Morgan health care conference in San … Continue Reading
Retail clinics have grown substantially in number and popularity since their emergence in the early 2000s. Retail clinics are limited healthcare clinics that operate outside of physician offices and hospitals, typically in pharmacies, grocery stores, and ”big box” stores like … Continue Reading
It’s deal time! The 2016 JP Morgan Healthcare Conference has set the tone for another successful year for healthcare investing. A company’s financial health is a key factor in the underwriting process for any type of loan and, in the … Continue Reading
A September 2015 Consero survey of general counsels (GCs) from mid-size to large U.S. hospital and health systems provides some interesting insight into the top issues facing legal departments.
Highlights include the following:
- 94% of surveyed GCs said they are
Scholar Rock has announced it has secured $36 million in series B financing.
Scholar Rock, based in Cambridge, Mass., is a biotechnology company focused on developing drugs that selectively target supracellular activation of growth factors in the disease microenvironment. … Continue Reading
OrbiMed has announced the closing of its next venture capital fund with $950 million in limited partner commitments.
Allena Pharmaceuticals has announced it has secured $53 million in series C financing.
Allena, based in Newton, Mass., is biopharmaceutical company focused on developing and commercializing nonsystemic oral protein therapeutics to treat metabolic and orphan diseases.
The financing round … Continue Reading
Our McGuireWoods colleagues published a piece about the recently released work plan for the OIG in 2016, provided here as Part 1 of 2. We closely review the annual release of this plan as it can provide valuable insights into … Continue Reading
Overall U.S. healthcare spending increased 5.3% in 2014 to reach $3.0 trillion, according to a report from CMS’ Office of the Actuary.
The study indicated the growth experienced in 2014 was primarily attributable to major coverage expansions under the … Continue Reading
Warburg Pincus has announced it has successfully raised its latest global fund, Warburg Pincus Private Equity XII.
The fund, launched in May 2015, has received commitments in excess of its $12 billion hard cap.
Wellspring Capital Management has announced it has acquired AdvoServ.
Wellspring, headquartered in New York, is a middle-market PE firm that manages more than $3 billion of private equity capital.
PE firm Warburg Pincus has announced it will invest up to $300 million in new pharmaceutical company Vertice Pharma.
Vertice Pharma, which has its U.S. headquarters in New Jersey, will focus on acquiring specialty pharmaceutical companies and products. It was … Continue Reading
Atreca has announced it has secured $56 million in series A funding.
Atreca, based in Redwood City, California, is a privately held biotechnology company developing therapeutics drawn from human immune responses, including anti-cancer immune responses.
The funding round was … Continue Reading